Togadia who went ‘missing’ to evade arrest found ‘semi-conscious’; VHP goes violent

News Network
January 15, 2018

Ahmedabad/Jaipur, Jan 16: There was high drama on Monday when Vishwa Hindu Parishad (VHP) international working president Pravin Togadia, who went "missing" after Rajasthan police came calling with an arrest warrant, was "found" from Kotarpur in Ahmedabad by an unidentified caller in an unconscious state. He was admitted to Chandramani Hospital in Shahibaug, Ahmedabad, with low blood sugar.

As VHP men rented the air with 'Jai Shri Ram' after Togadia, who gets Z-plus security, director of Chandramani Hospital Dr Roopkumar Agarwal said, "Togadia was shifted to hospital by EMRI 108 emergency service around 9.15pm in a semi-conscious state suffering from hypoglycemia (low blood sugar). After he was given treatment, his condition stabilised. He is not in a position to give detailed statement, but will soon be well."

Additional Commissioner of Police (Sector-II) Ashok Yadav said: "Togadiya was found with low blood sugar. We will know the details when he is in a position to give a detailed statement."

Togadia's hospitalisation brought curtains down on the day-long drama albeit with several questions remaining unanswered, primary being the whereabouts of Togadia all through Monday.

The day saw VHP leaders allege "foul-play" when Togadia went missing from the VHP office after Rajasthan cops came calling with arrest warrant. Gujarat VHP general secretary Ranchhod Bharwad, who had alleged that Togadia was picked up by cops, raised questions over his safety after both Rajasthan and Ahmedabad police claimed that Togadia was not in their custody. Bharwad filed a complaint for missing person to the Ahmedabad crime branch on Monday evening.

Around 8.30pm, EMRI 108 got a call that a man in his 60s was found unconscious in Kotarpur. The man was shifted to Chandramani Hospital and identified as Togadia.

"The great news is that Togadiaji has been found. He is stable but not in a position to speak. Doctors have asked that he should be allowed to rest. Police will conduct a detailed probe into the incident," Bharwad said.

There were tense moments amid rumours of Togadia being picked up by Rajasthan police in connection with a case of disobeying government's orders in 2002 even as suspicion deepened over the "missing" leader after cops denied his detention or arrest.

Ahmedabad police confirmed that Rajasthan cops had come to arrest him in an old case of disobedience to public order but denied his detention or arrest. Police claimed Togadia was last seen early on Monday morning and was untraceable ever since.

JK Bhatt, JCP (crime), told mediapersons that Rajasthan police team had come to Sola police station at 10.45am on Monday to serve the arrest warrant. "A local police team had accompanied Rajasthan cops to Togadia's residence but he was not found there. We then inquired at VHP office in Paldi where State Reserve Police jawan on duty said Togadia had left at 10.45am on Monday in an auto with a bearded man," said Bhatt.

Jay Shah, a close aide of Togadia and VHP spokesperson, said: "Recently attempts were made by certain elements of RSS and BJP to remove Pravinbhai from the post of working president of VHP. While those attempts failed, he is being targeted being the lone Hindu voice pressurizing for building Ram Mandir and issues like conversion and love jihad."

As per Rajasthan police, Togadia had held a public meeting in Gangapur city in Sawai Madhopur district in April 2002 despite a ban on his entry. Yogendra Faujdar, additional SP, told TOI: "Togadia had flouted the order of CrPC Section 144 for unlawful assembly. Thus, a case of IPC Section 188 (Disobedience to order duly promulgated by public servant) was registered against him."

"Police teams had visited Ahmedabad several times to serve summons. When they could not be delivered, a bailable warrant was issued. When that also could not be delivered, an arrest warrant was issued against him a fortnight ago. A team visited Ahmedabad with the warrant. The team went to Togadia's residence but he could not be found," said Faujdar.

Comments

VGP
 - 
Tuesday, 16 Jan 2018

in simple words its called DARPOK or Hypocrite. When thousands of people fighting the innocent by the orders of such leaders and goin to jail. Why is he escaping from goin to jail. This shows why WE SHOULD THINK before following the orders of such hypocrites... 

Peacelover
 - 
Tuesday, 16 Jan 2018

In our film insdustry notable to find such great actor. A well planned drama wait and see  what will happen where it will take turn aage aage kya hota hai.

Never looks like a sic person  present photo not suit with  above news.

 

s
 - 
Tuesday, 16 Jan 2018

you can run from the police but you cannot run from fate

abbu
 - 
Tuesday, 16 Jan 2018

HAHAHHAHAHHA what a politics game. 2002 case and police going to arrest monday 2018. Now BJP / RSS not require togadia.. so they want to sideline him. thats the reason togadia is arresting. or else no chance the police have DARE to arrest him. become old. then no support frm bjp/rss. THIS IS LESSON FOR THE SO CALLED RSS. DONT WASTE UR TIME. DEVELOP YOURSELF AND UR FAMILY.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
January 22,2020

Davos, Jan 22: President Donald Trump has said that the US is watching the developments between India and Pakistan over Kashmir "very closely" and repeated his offer to "help" resolve the longstanding dispute between the two neighbours as he met Prime Minister Imran Khan on the sidelines of the World Economic Forum here in the Swiss ski resort.

Addressing the media with the Pakistan Prime Minister prior to their private meeting on Tuesday, President Trump asserted that trade and borders were both critical points for discussion, while Khan said that for him, Afghanistan was the top priority.

Trump told Khan, whom he referred to as "my friend", that he would speak to Prime Minister Narendra Modi about the ongoing Kashmir issue. The US president is expected to visit India in the coming weeks, marking his first visit after taking up his post in the White House.

"What's going on between Pakistan and India … if we can help, we certainly will be willing to. We have been watching it very closely and it's an honour to be here with my friend," he said.

"The Pakistan-India conflict is a very big issue for us in Pakistan and we expect the US to always play its part in deescalating the tensions, because no other country can," Khan said.

President Trump has repeatedly offered to mediate following India's August 5 decision to revoke the special status to Jammu and Kashmir and bifurcate the state into two Union Territories, evoking strong reaction from Pakistan which has been trying to internationalise the Kashmir issue.

New Delhi has defended the move, saying Jammu and Kashmir is an integral part of India and the issue was strictly internal to the country, and the special status provisions only gave rise to terrorism in Jammu and Kashmir.

"The country took the decision of abrogation of Article 370, which had only given separatism and terrorism to that state," Prime Minister Narendra Modi said at a function in October last year.

This is the third meeting between Trump and Khan since Pakistan premier assumed office in 2018 and it came against the backdrop of Pakistan Foreign Minister Shah Mehmood Qureshi's recent trip to the US, amid reports that the US and Afghan Taliban were close to striking a peace deal.

"There are issues we want to talk about. The main issue is Afghanistan because it concerns the US and Pakistan. Fortunately, we are on the same page. Both of us are interested in peace there and an orderly transition in Afghanistan with talks with Taliban and the government," Khan said.

When a reporter asked Trump if he would visit Pakistan considering he was already set to visit India, the US president said he was meeting the Pakistan premier in Davos.

"Well, we're visiting right now. So we don't really have to. I wanted to say that from a relationship standpoint, we got a great relationship. From the standpoint our two countries, we're getting along very well. I would say we've never been closer with Pakistan the way we're right now. And this is a big statement," Trump said.

Khan left for Switzerland to attend the World Economic Forum and meet the world leaders, including President Trump, on the sidelines of the annual event which kicked off at the ski resort town of Davos on Tuesday.

The four-day summit marks the 50th anniversary of the forum.

A total of 53 heads of State are on the guest list. Nearly 3,000 participants from 118 countries are expected to attend the event during which political leaders, business executives, heads of international organisations and civil society representatives are set to deliberate on contemporary economic, geopolitical, social and environmental issues.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 29,2020

New Delhi, Mar 29: The total confirmed coronavirus cases in India rose to 979, including 48 foreigners, according to the Ministry of Health and Family Welfare on Sunday.
There are 867 active cases of the disease as of Sunday, out of the total confirmed cases, while 87 persons have also been cured and discharged or migrated.
The number of deaths due to the infection rose to 25.
Maharashtra and Kerala, with 186 and 182 cases, have two of the highest number of positive cases in the country, with Maharashtra also recording six deaths due to the disease.
The Central government has taken many stringent measures to prevent the further spread of the disease with a 21-day nationwide lockdown being imposed.
The disease which originated from Wuhan, China has so far close to 6 lakh reported cases from around the world with more than 25 thousand deaths being reported due to it, as per World Health Organisation on March 28. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.